Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Cerevance

Cerevance

Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

April 14, 2020
Cerevance raises a $45,000,000 series B round.

Funding Rounds

Patents

Further Resources

Title
Author
Link
Type
Date

References

Golden logo
By using this site, you agree to our Terms & Conditions.